do glp 1 reduce cancer risk GLP-1s appear to cut risk. Researchers are asking why and how : NPR Glucagon-like peptide 1 receptor agonists

M., Schuermans, A

American heart association

However, it is important to recognize that ongoing use is typically required to maintain these benefits

Ongoing support Get access to Shed Health Coaching, unlimited provider follow-ups, step-by-step health courses, and more.* Start your weight-loss journey with Wegovy Start your weight-loss journey with Wegovy Supports healthy metabolic function* Supports weight management* *This information is for educational purposes only and is not a substitute for professional medical advice

The state Office of the Health Insurance Commissioner wrote in a report in May that spending on GLP-1s such as Ozempic, Weygovy, Mounjaro and Zepbound "nearly tripled" from 2021 to 2023 and was the "primary driver" behind a 7.8% increase in total health care spending in 2023